535 related articles for article (PubMed ID: 30554355)
1. Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation.
Castelnovo V; Caminiti SP; Riva N; Magnani G; Silani V; Perani D
Neurol Sci; 2019 Mar; 40(3):515-521. PubMed ID: 30554355
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers.
Tondo G; Mazzini L; Caminiti SP; Sarnelli MF; Corrado L; Matheoud R; D'Alfonso S; Cantello R; Sacchetti GM; Perani D; Comi C; De Marchi F
Neuroimage Clin; 2022; 36():103222. PubMed ID: 36223668
[TBL] [Abstract][Full Text] [Related]
3. The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients.
Cistaro A; Pagani M; Montuschi A; Calvo A; Moglia C; Canosa A; Restagno G; Brunetti M; Traynor BJ; Nobili F; Carrara G; Fania P; Lopiano L; Valentini MC; Chiò A
Eur J Nucl Med Mol Imaging; 2014 May; 41(5):844-52. PubMed ID: 24445987
[TBL] [Abstract][Full Text] [Related]
4. Brain ¹⁸F-FDG and ¹¹C-PiB PET findings in two siblings with FTD/ALS associated with the C9ORF72 repeat expansion.
Martikainen MH; Gardberg M; Jansson L; Röyttä M; Rinne JO; Kaasinen V
Neurocase; 2014 Apr; 20(2):150-7. PubMed ID: 23216213
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal imaging in
Floeter MK; Bageac D; Danielian LE; Braun LE; Traynor BJ; Kwan JY
Neuroimage Clin; 2016; 12():1035-1043. PubMed ID: 27995069
[TBL] [Abstract][Full Text] [Related]
6. Network degeneration and dysfunction in presymptomatic
Lee SE; Sias AC; Mandelli ML; Brown JA; Brown AB; Khazenzon AM; Vidovszky AA; Zanto TP; Karydas AM; Pribadi M; Dokuru D; Coppola G; Geschwind DH; Rademakers R; Gorno-Tempini ML; Rosen HJ; Miller BL; Seeley WW
Neuroimage Clin; 2017; 14():286-297. PubMed ID: 28337409
[TBL] [Abstract][Full Text] [Related]
7. Screening for the C9ORF72 repeat expansion in a greek frontotemporal dementia cohort.
Kartanou C; Karadima G; Koutsis G; Breza M; Papageorgiou SG; Paraskevas GP; Kapaki E; Panas M
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):152-154. PubMed ID: 29166782
[TBL] [Abstract][Full Text] [Related]
8. The involvement of language-associated networks, tracts, and cortical regions in frontotemporal dementia and amyotrophic lateral sclerosis: Structural and functional alterations.
Tahedl M; Tan EL; Chipika RH; Lope J; Hengeveld JC; Doherty MA; McLaughlin RL; Hardiman O; Hutchinson S; McKenna MC; Bede P
Brain Behav; 2023 Nov; 13(11):e3250. PubMed ID: 37694825
[TBL] [Abstract][Full Text] [Related]
9. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].
Tomiyama H
Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305
[TBL] [Abstract][Full Text] [Related]
10. The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET trumps syndrome.
Adeli A; Savica R; Lowe VJ; Vemuri P; Knopman DS; Dejesus-Hernandez M; Rademakers R; Fields JA; Crum BA; Jack CR; Petersen RC; Boeve BF
Neurocase; 2014; 20(1):110-20. PubMed ID: 23199140
[TBL] [Abstract][Full Text] [Related]
11. Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion.
De Vocht J; Blommaert J; Devrome M; Radwan A; Van Weehaeghe D; De Schaepdryver M; Ceccarini J; Rezaei A; Schramm G; van Aalst J; Chiò A; Pagani M; Stam D; Van Esch H; Lamaire N; Verhaegen M; Mertens N; Poesen K; van den Berg LH; van Es MA; Vandenberghe R; Vandenbulcke M; Van den Stock J; Koole M; Dupont P; Van Laere K; Van Damme P
JAMA Neurol; 2020 Aug; 77(8):1008-1017. PubMed ID: 32421156
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.
Hsiung GY; DeJesus-Hernandez M; Feldman HH; Sengdy P; Bouchard-Kerr P; Dwosh E; Butler R; Leung B; Fok A; Rutherford NJ; Baker M; Rademakers R; Mackenzie IR
Brain; 2012 Mar; 135(Pt 3):709-22. PubMed ID: 22344582
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET in presymptomatic C9orf72 mutation carriers.
Popuri K; Beg MF; Lee H; Balachandar R; Wang L; Sossi V; Jacova C; Baker M; Shahinfard E; Rademakers R; Mackenzie IRA; Hsiung GR
Neuroimage Clin; 2021; 31():102687. PubMed ID: 34049163
[TBL] [Abstract][Full Text] [Related]
14. Brain FDG-PET changes in ALS and ALS-FTD.
Renard D; Collombier L; Castelnovo G; Fourcade G; Kotzki PO; LaBauge P
Acta Neurol Belg; 2011 Dec; 111(4):306-9. PubMed ID: 22368970
[TBL] [Abstract][Full Text] [Related]
15. Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study.
Van Laere K; Vanhee A; Verschueren J; De Coster L; Driesen A; Dupont P; Robberecht W; Van Damme P
JAMA Neurol; 2014 May; 71(5):553-61. PubMed ID: 24615479
[TBL] [Abstract][Full Text] [Related]
16. Different FDG-PET metabolic patterns at single-subject level in the behavioral variant of fronto-temporal dementia.
Cerami C; Dodich A; Lettieri G; Iannaccone S; Magnani G; Marcone A; Gianolli L; Cappa SF; Perani D
Cortex; 2016 Oct; 83():101-12. PubMed ID: 27498041
[TBL] [Abstract][Full Text] [Related]
17. The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance.
Giannoccaro MP; Bartoletti-Stella A; Piras S; Casalena A; Oppi F; Ambrosetto G; Montagna P; Liguori R; Parchi P; Capellari S
J Alzheimers Dis; 2018; 62(2):687-697. PubMed ID: 29480190
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort.
Van Mossevelde S; van der Zee J; Gijselinck I; Engelborghs S; Sieben A; Van Langenhove T; De Bleecker J; Baets J; Vandenbulcke M; Van Laere K; Ceyssens S; Van den Broeck M; Peeters K; Mattheijssens M; Cras P; Vandenberghe R; De Jonghe P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C;
Brain; 2016 Feb; 139(Pt 2):452-67. PubMed ID: 26674655
[TBL] [Abstract][Full Text] [Related]
19. Brain Stem Glucose Hypermetabolism in Amyotrophic Lateral Sclerosis/Frontotemporal Dementia and Shortened Survival: An
Zanovello M; Sorarù G; Campi C; Anglani M; Spimpolo A; Berti S; Bussè C; Mozzetta S; Cagnin A; Cecchin D
J Nucl Med; 2022 May; 63(5):777-784. PubMed ID: 34503963
[TBL] [Abstract][Full Text] [Related]
20. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72.
Boeve BF; Boylan KB; Graff-Radford NR; DeJesus-Hernandez M; Knopman DS; Pedraza O; Vemuri P; Jones D; Lowe V; Murray ME; Dickson DW; Josephs KA; Rush BK; Machulda MM; Fields JA; Ferman TJ; Baker M; Rutherford NJ; Adamson J; Wszolek ZK; Adeli A; Savica R; Boot B; Kuntz KM; Gavrilova R; Reeves A; Whitwell J; Kantarci K; Jack CR; Parisi JE; Lucas JA; Petersen RC; Rademakers R
Brain; 2012 Mar; 135(Pt 3):765-83. PubMed ID: 22366793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
